Product Name |
Lopinavir D8 |
Alternate Names |
Lopinavir Stable Isotopes, Stable Isotopes of Lopinavir |
CAT No. |
CS-O-03071
|
CAS No. |
1224729-35-4 |
Category |
Stable Isotopes |
Stock |
IN-Stock
|
Mol. Wt. |
636.85 g/mol |
Mol. For. |
C₃₇H₄₀D₈N₄O₅
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Lopinavir |
Therapeutic |
Antiretroviral / Anti-HIV |
Smileys |
O=C(N[C@H](C[C@H](O)[C@@H](NC(COC(C(C)=CC=C1)=C1C)=O)CC2=CC=CC=C2)CC3=CC=CC=C3)[C@](N(CCCN4)C4=O)([2H])C(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H] |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Lopinavir D8 is a deuterated analog of the antiretroviral drug lopinavir, which is used to treat human immunodeficiency virus (HIV) infections. Deuterated drugs are those that have been modified by replacing one or more hydrogen atoms with deuterium, a stable isotope of hydrogen. This modification can enhance the drug's pharmacokinetic properties, such as its bioavailability and metabolic stability.
Lopinavir D8 is typically administered as a combination therapy with another antiretroviral drug, ritonavir. The two drugs work together to inhibit the HIV protease enzyme, which is necessary for the virus to replicate. This inhibition can reduce the viral load in HIV-infected patients and slow down the progression of the disease.
In terms of chemical information, Lopinavir D8 has a molecular formula of C37H47D8N3O5S and a molecular weight of 705.03 g/mol. It is a white to off-white powder that is slightly soluble in water and freely soluble in ethanol. The drug is metabolized in the liver and excreted in the feces and urine.
Like other antiretroviral drugs, Lopinavir D8 can cause side effects such as nausea, diarrhea, and headache. Patients taking this drug should also be monitored for potential drug interactions and liver function abnormalities. Overall, Lopinavir D8 is an important treatment option for HIV-infected patients and its deuterated form may offer advantages over the non-deuterated version.